Clinical Trials
3 trialsNCT03742323 2021-09-05
REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia
PETHEMA Foundation
Phase 1/2 Terminated
NCT01090414 2019-08-28
An Extension Study for Subjects Who Are Deriving Benefit With Idelalisib (GS-1101; CAL-101) Following Completion of a Prior Idelalisib Study
Gilead Sciences
Phase 1/2 Terminated
NCT01306643 2018-11-19
Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma
Gilead Sciences
Phase 1/2 Completed